SOURCE: Elsevier Business Intelligence

Elsevier Business Intelligence

April 23, 2010 14:37 ET

Multinational Medtechs and Medtech VCs Will Reveal Latest Investment Preferences at Elsevier's 'Medical Device Investor Day' in Boston on June 9, 2010

Event Precedes 'IN3 East', the East Coast's Biggest Annual Strategic Partnership and Investment Meeting for Medtech Execs

BOSTON, MA--(Marketwire - April 23, 2010) -  Elsevier Business Intelligence, the medtech industry's leading provider of strategic partnership and investment conferences, announced today that it will host 'Medical Device Investor Day' on June 9 in Boston at The Westin Copley Place. This major event is the prelude to Elsevier's 'IN3 East' investment conference, also being held at The Westin Copley Place, on June 10-11, 2010.

Medical Device Investor Day is a 'must attend' event for medical technology executives who are interested in what the leaders of the industry are thinking, doing, and planning in terms of investment. Senior execs from leading medical technology companies and VC firms -- such as Boston Scientific, Ascension Health Ventures, Baird Venture Partners, HLM Venture Partners and Nexus Medical Partners -- will speak candidly about what interests them most in the medtech space today.

Medical Device Investor Day will be followed by IN3 East on June 10-11 at The Westin Copley Place, Boston. IN3 East is the largest annual strategic partnership and investment meeting for senior-level medical technology executives. Several hundred venture capital firms and medical technology companies are expected to be represented at IN3 East to hear about the latest innovations and investment opportunities from more than 50 emerging medical technology companies seeking funding and/or strategic partnerships.

For more information about IN3 East and Medical Device Investor Day, please contact: Kristy Kennedy at 1-480-985-9512 or Kayleen Kell at 1-888-290-2225 (USA only), or email IN3@Elsevier.com.

Additional IN3 events in 2010 -- Oct. 27-29, IN3 Summit, San Francisco, Grand Hyatt. Feb. 22-24, 2011, IN3 West 2011, Las Vegas, The Venetian Resort. For more information, please contact: Kristy Kennedy at 1-480-985-9512 or Kayleen Kell at 1-888-290-2225 (USA only), or email IN3@Elsevier.com.

About Elsevier Business Intelligence
Elsevier Business Intelligence, an Elsevier company, is a global information supplier providing business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry. Through a range of products including publications, conferences, databases and reports, Elsevier Business Intelligence places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge, by providing the perfect combination of news and information together with penetrating insight and analysis. Elsevier Business Intelligence (http://www.elsevierbi.com) has offices in the U.S. in Bridgewater, N.J.; Norwalk, Conn.; Rockville, Md.; and Irvine, Calif.

About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Contact Information

  • Contact:
    Ronald Trahan, APR
    Ronald Trahan Associates Inc.
    508-359-4005, x108